• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
Mersana Therapeutics released FY2025 Q3 earnings on November 14 Pre-Market EST, actual revenue USD 11.01 M (forecast USD 14.2 M), actual EPS USD -1.5112 (forecast USD -1.6112)
14:30
Mersana Therap released FY2025 9 Months Earnings on November 14 Pre-Market EST, with actual revenue of USD 16.82 M and EPS of USD -11.2285
14:30
Nov7
Mersana Therap to Release FY2025 Q3 Earnings on November 14 Pre-Market EST, Forecast Revenue USD 14.2 M, EPS USD -1.6112
00:06
Aug13
Mersana Therap released FY2025 Semi-Annual earnings on August 13 During-Market EST, actual revenue USD 5.81 M, actual EPS USD -9.7173
20:00
Mersana Therap released FY2025 Q2 earnings on August 13 During-Market EST, actual revenue USD 3.056 M (forecast USD 6.057 M), actual EPS USD -4.872 (forecast USD -4.0725)
20:00
Aug6
Mersana Therap to Release FY2025 Q2 Earnings on August 13 During-Market (EST), Forecast Revenue USD 6.057 M, EPS USD -4.0725
00:08

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 11.01 M, Net Income -7.545 M, EPS -1.5112

Aug13
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.056 M, Net Income -24.3 M, EPS -4.872

Jul28
Reverse Stock Split(EST)

1-for-25 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More